Thank you for subscribing!
Next Investors Archived Aug 01, 2021
eSense-Lab Ltd (ASX: ESE) has signed a research agreement with the Israeli Ministry of Health to commence a research project at the Central Virology lab in the Chaim Sheba Medical Centre — the largest hospital in Israel — to test its proprietary TRP-ENV™ compounds for a coronaviruses.
Finfeed Archived Jul 15, 2020
eSense-Lab Limited (ASX:ESE) has achieved a number of key strategic milestones and contracts during the two recent quarters, leaving it well positioned to increase sales and revenue growth.
Finfeed Archived Jul 07, 2020
eSense-Lab Limited (ASX:ESE) is executing on its expansion into the US market — the world’s largest consumer base for terpene based products — entering an exclusive sales agency agreement with Blue Science Solutions LLC for the distribution of its future terpene based sanitiser products.
Next Investors Archived Jun 19, 2020
Backed by a new leadership team, ASX-listed biotech junior, eSense-Lab (ASX:ESE) is implementing a new business model that sees it enter joint venture (JV) agreements to quickly reach multiple revenue-generating markets.
Get expert stock analysis direct in your inbox
Finfeed Archived Jun 18, 2020
eSense-Lab (ASX:ESE) has entered into a joint venture with Wise Wine Ltd, a family-owned wine company based in Western Australia
Finfeed Archived Jun 15, 2020
eSense-Lab Limited (ASX: ESE) has entered a JV with ANC Enterprises to provide specific terpenes uniquely developed for a range of skin care, hair care and hand sanitiser products. ANC will formulate and manufacture the resulting products containing ESE’s proprietary terpene mixes.
Finfeed Archived May 29, 2020
Cannabis enthusiasts purchase terps and incorporate them into everything from homemade brownies to vape juice. But there’s one industry that’s had surprisingly less of a symbiotic relationship with terpenes than anyone might have expected; namely the cannabis industry.
Join Our Mailing List
